Morten Grupe Larsen

Title: Morten Grupe Larsen: Innovator in Epilepsy Treatment

Introduction

Morten Grupe Larsen is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of epilepsy and seizures. His innovative work focuses on the development of novel compounds that activate Kv7 potassium channels.

Latest Patents

Morten holds a patent for "Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures." This invention provides novel compounds, specifically compounds of Formula I, which are designed to activate Kv7 potassium channels. The patent also covers pharmaceutical compositions that include these compounds and their applications in treating disorders responsive to Kv7 potassium channel activation. He has 1 patent to his name.

Career Highlights

Morten is currently employed at H. Lundbeck A/S, a leading global pharmaceutical company specializing in brain diseases. His work at Lundbeck has allowed him to focus on innovative solutions for neurological disorders, contributing to advancements in epilepsy treatment.

Collaborations

Morten collaborates with talented professionals in his field, including Jelena Ivkovic and Mario Rottländer. These partnerships enhance the research and development efforts at H. Lundbeck A/S, fostering an environment of innovation.

Conclusion

Morten Grupe Larsen is a dedicated inventor whose work in developing Kv7 potassium channel openers represents a significant advancement in the treatment of epilepsy. His contributions to the pharmaceutical industry continue to impact the lives of those affected by neurological disorders.